Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030193 (
pain
)
261,466
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Total parenteral nutrition (TPN), specifically amino acid infusions, has been shown to increase the ventilatory response to inhaled
CO2
. The hypothesis tested was that morphine sulfate (known to depress ventilatory
CO2
responsiveness) would diminish the augmented ventilatory
CO2
response in patients receiving TPN. The influence of morphine on hyperoxic hypercapnic ventilatory response (assessed by the Read rebreathing technique) was therefore examined in four otherwise healthy subjects who were receiving TPN at home for long-standing nutritional support secondary to malabsorption syndrome (short-bowel syndrome), and in a control group of four healthy subjects who were not receiving TPN. The slope and intercept of the
CO2
response was estimated by linear regression on the relationship between ventilation (VE) and end-tidal PCO2 (PETCO2). Administration of morphine in the non-TPN group elicited the expected decrease in the VE-PETCO2 slope. In contrast, morphine administration was associated with an increase in the VE-PETCO2 slope in the TPN group. While this investigation does not provide a direct indication of the mechanisms underlying the augmenting action of morphine on the ventilatory response to
CO2
in subjects receiving TPN, it does suggest that patients on TPN who demonstrate no impairment of ventilatory control may be given normal doses of morphine sulphate (ie, as for
pain
control or preoperative medication) with no increased concern for an adverse ventilatory outcome.
...
PMID:The effect of total parenteral nutrition and morphine on ventilation. 212 45
Two studies evaluated the intraoperative and postoperative use of ketorolac, a nonopioid analgesic. Compared with the opioid analgesic alfentanil, ketorolac administered intraoperatively exerted no adverse effects on cardirespiratory functions (i.e., no changes in heart rate, arterial partial pressure of
carbon dioxide
, or mean arterial pressure, and no associated apnea). Analgesic efficacy of both agents was judged to be equal. The study of postoperative infusion of ketorolac in combination with patient-controlled administration of morphine confirmed the analgesic efficacy of ketorolac when used after upper abdominal surgery. The narcotic-sparing effect was demonstrated by the finding that patients who received placebo self-administered over 40% more morphine in the first 24 hours after surgery than those in the ketorolac group. The better
pain
scores with ketorolac may be associated with the reduction in unpleasant morphine-related side effects or with the provision of continuous background analgesia. The lack of respiratory depression with ketorolac, which would be anticipated from its inability to bind to central opioid receptors, was also demonstrated. In the placebo group, arterial partial pressure of
carbon dioxide
was significantly increased postoperatively, whereas a similar increase was not found in the ketorolac group. Results of the two investigations demonstrate the absence of opioid effects with ketorolac, and support its use for intraoperative and postoperative analgesia in patients undergoing major surgery.
...
PMID:Parenteral ketorolac: opiate-sparing effect and lack of cardiorespiratory depression in the perioperative patient. 212 59
The magnitude and duration of analgesia and respiratory depression induced by fentanyl (1.0, 2.0, and 4.0 micrograms/kg) and sufentanil (0.1, 0.2, and 0.4 microgram/kg) after intravenous administration over 30 s were measured in 30 healthy young adult male volunteers divided into three groups and studied in a double-blind, randomized fashion. Each volunteer received one dose of fentanyl or sufentanil and no sooner than 48 h later, the corresponding equipotent dose of the other opioid. End-tidal
CO2
and ventilatory and occlusion pressure responses to
CO2
rebreathing were used to measure drug-induced respiratory effects. Analgesic effects were assessed by changes in the
pain
threshold to electric shock applied to the forearm. Plasma levels of fentanyl and sufentanil were measured by radioimmunoassay. Testing and sampling intervals were 5, 30, 60, 90, 120, 240, 300, and 360 min after drug administration. The magnitude and duration of depression of the ventilatory and occlusion pressure response were significantly less with sufentanil compared with fentanyl, irrespective of dose. Ventilatory and occlusion pressure responses returned to control values by 30 and 30 min, respectively, after sufentanil and by 240 and 120 min, respectively, after fentanyl. Statistically significant elevations of the
pain
threshold were, however, greater and longer lasting after sufentanil compared with fentanyl.
Pain
threshold returned to control values 180 min after sufentanil but only 90 min after fentanyl. These results suggest that sufentanil may provide better patient comfort with less respiratory depression than does fentanyl.
...
PMID:Differences in magnitude and duration of opioid-induced respiratory depression and analgesia with fentanyl and sufentanil. 197 32
In 179 consecutive laparoscopies for infertility (n = 105),
pain
(n = 60), or both problems (n = 14), endometriosis was diagnosed in 77%, 82%, and 86%, respectively. Eighty implants with positive histology and with careful assessment of depth were sampled by
CO2
laser excision from 53 patients. Deep (greater than or equal to 5 mm), intermediate (2 to 4 mm), and superficial (less than 1 mm) infiltration was found in 48%, 35%, and 17% of implants, respectively. Deep infiltration was observed in the pouch of Douglas (55%) and at the uterosacrals (34%), but was absent from the ovarian fossas. Deep implants were found to be active in 68%. At an intermediate depth, however, only 25% of implants were active, whereas 58% of superficial foci showed activity. Deep implants were in phase with the endometrium in 74%. At an intermediate depth, however, only 38% showed regular cyclicity, whereas 57% of superficial implants were in phase with the cycle. Deep infiltration occurred through loose connective tissue septa into the fibromuscular tissue and was always stopped at the underlying fat tissue. Very deep implants (greater than 10 mm) were found exclusively in patients with
pain
; superficial implants, on the contrary, were found most frequently in patients with infertility (83%).
...
PMID:Deeply infiltrating pelvic endometriosis: histology and clinical significance. 214 Sep 94
The results of using immediate trocar insertion were compared to prior peritoneal insufflation with a Verres needle for laparoscopic tubal sterilization, with respect to total operative time, number of instrumental insertions, volume of
CO2
required and complications. 102 women had a direct trocar procedure; 110 the prior needle insertion, selected randomly. Laparoscopy was done with a single-puncture instrument, triple cautery, and upper abdominal inspection under video control. Times were noted from the incision for the Verres needle to trocar insertion, from trocar incision to confirmation of correct placement of the laparoscope, and from then until cutting of the last suture. Total operating time was less in the direct trocar group, 7 minutes 30 seconds, vs. 9 minutes 40 second, p0.0001. 8 women in the direct trocar group had multiple trocar insertions, compared to 24 women in the needle group. The direct trocar group received less
CO2
, 2.32 L compared to 2.67 for the needle group, p0.001. There were minor injuries to the omentum not requiring intervention in 7 women in the needle group, but 4 in the trocar group. There were 2 complications: a woman in the direct trocar group had to have laparotomy because of insertion of the trocar into the large bowel, which was adherent to the abdominal wall. Another woman in the needle group returned 3 days later with
pain
, fever and ileus, and recovered after treatment. These observations suggest that direct trocar insertion is safer for patients in terms of operative time, need for additional
CO2
, and especially risk of multiple instrument insertions, always a blind procedures with potential for injury.
...
PMID:Direct trocar insertion vs. Verres needle use for laparoscopic sterilization. 214 89
Unilateral tight ligation of about half of the sciatic nerve in rats rapidly produces sympathetically dependent neuropathic
pain
which lasts many months and resembles causalgia in humans. The sensory abnormalities detected at the plantar side of the hindpaws include: (1) nocifensive responses to repetitive light touch (allodynia); (2) bilateral reduction in withdrawal thresholds to repetitive von-Frey hair stimulation (mechanical hyperesthesia); (3) bilateral reduction in withdrawal thresholds to
CO2
laser heat pulses; and (4) unilateral increase in response duration to an intense laser heat pulse (thermal hyperalgesia). Using neonatal capsaicin treatment, we determined the type of afferent fiber remaining in the partially injured nerve, which mediates these disorders. Capsaicin, which destroys most C- and some A delta-fibers in peripheral nerves, had no effect on the touch-evoked allodynia and mechanical hyperesthesia that are produced by partial sciatic nerve injury. These disorders were, therefore, mediated by myelinated fibers. In contrast, thermal hyperalgesia failed to develop in capsaicin-treated rats following partial nerve injury. Thus, thermal hyperalgesia produced by partial nerve injury appears to be mediated by heat-nociceptive C-fibers.
...
PMID:A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats. 221 58
Nalbuphine hydrochloride, an agonist-antagonist opioid, is reported to reverse the respiratory depression of moderate doses of fentanyl (20 micrograms.kg-1) and still provide good analgesia. We report four patients having abdominal aortic aneurysm repair in which we attempted to reverse the respiratory depression of large doses of fentanyl (50-75 micrograms.kg-1) with nalbuphine (0.3 mg.kg-1, 0.1 mg.kg-1 or 0.05 mg.kg-1). Nalbuphine reversed respiratory depression in all four patients and the respiratory rate increased from 10 to 23 breaths per minute, end-tidal
CO2
decreased from 7.0 +/- 0.3 per cent to 5.6 +/- 0.7 per cent, and peak inspiratory pressure after 0.1 seconds increased from 4 +/- 1.4 to 13 +/- 2.6 mmHg. However, hypertension, increased heart rate, and significant increase in analogue
pain
scores accompanied reversal of respiratory depression. Agitation, nausea, vomiting, and cardiac dysrhythmias also were observed frequently. We do not recommend the use of nalbuphine to facilitate early extubation of the trachea after large doses of fentanyl for abdominal aortic surgery.
...
PMID:Side effects of nalbuphine while reversing opioid-induced respiratory depression: report of four cases. 165
The effects of the cholecystokinin antagonist devazepide on analgesia and respiratory depression induced by morphine in squirrel monkeys were examined.
Pain
thresholds were determined using the tail withdrawal procedure, in which monkeys restrained in chairs kept their tails in cool (35 degrees C) water for at least 20 sec, but withdrew them from warm (55 degrees C) water in less than 4 sec. Morphine produced a dose-related increase in tail withdrawal latencies from warm water. Devazepide (injected i.p. or p.o.) had no effect on tail withdrawal latencies when given alone but enhanced the analgesic effects of morphine. The devazepide dose-response curve for morphine enhancement was bell-shaped with doses of 3, 10, 30 and 100 micrograms/kg injected i.p. increasing morphine analgesia whereas higher and lower dose did not. In a separate group of monkeys, morphine produced dose-dependent decreases in respiratory rate and oxygen tension and increases in
carbon dioxide
tension. In contrast to its effects on morphine analgesia, devazepide had no effect on the various indices of morphine-induced respiratory depression. These data suggest that devazepide may have therapeutic utility as an adjuvant to morphine analgesia allowing lower dose of the opiate to be used to relieve
pain
and reducing the risk of opiate-induced respiratory depression.
...
PMID:The cholecystokinin receptor antagonist devazepide enhances morphine-induced analgesia but not morphine-induced respiratory depression in the squirrel monkey. 226 99
We have used 31phosphorus magnetic resonance spectroscopy (31P-MRS) to study foot muscle metabolism in patients with peripheral vascular disease. Sixteen patients with calf claudication, 32 patients with rest
pain
and 13 control subjects had spectra collected from the foot muscle, Extensor digitorum brevis, ankle pressures measured and, in most cases, transcutaneous O2 and
CO2
recordings made over the foot. The intracellular pH and the ratio of inorganic phosphate to phosphocreatine (Pi/PCr) obtained from the MR spectra were significantly higher (p less than 0.005 and p less than 0.02, respectively) in the muscle of patients with rest
pain
and were particularly high in those with gangrene or ulceration. Ankle pressures and transcutaneous O2 and
CO2
measurements failed to distinguish those patients with advanced peripheral ischaemia. These results suggest that MRS measurements of metabolic changes in foot muscle are useful in the detection and quantitation of significant distal ischaemia.
...
PMID:Muscle ischaemia in peripheral vascular disease studied by 31P-magnetic resonance spectroscopy. 227 75
A 69 yr old man was admitted with a 10 day history of fever, arthromyalgia, dyspnoea, dry cough and pleuritic
pain
. Temperature was 38 degrees C; tachypnoea 36 rpm. Extensive crackles were audible over both upper lung fields. Chest X-ray showed bilateral alveolar infiltrates. Forced vital capacity was 49% of predicted, and
carbon monoxide
transfer coefficient was 32% of predicted value. The patient had been taking carbamazepine for one month because of a trigeminal neuralgia. After withdrawal of the drug he gradually recovered.
...
PMID:Carbamazepine and the lung. 229 88
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>